Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill.
Two structurally different forms of activated human Factor IX (Factor IXa alpha and IXa beta) have been previously reported to have essentially identical clotting activity in vitro. Although it has been shown that activated Factor IX Chapel Hill, an abnormal Factor IX isolated from the plasma of a patient with mild hemophilia B, and normal Factor IXa alpha are structurally very similar, the clotting activity of activated Factor IX Chapel Hill is much lower (approximately fivefold) than that of normal Factor IXa beta. In the present study we have prepared activated Factor IX by incubating human Factor IX with calcium and Russell's viper venom covalently bound to agarose. Fractionation of the activated Factor IX by high-performance liquid chromatography demonstrated the presence of both Factors IXa alpha and IXa beta. On the basis of active site concentration, determined by titration with antithrombin III, the clotting activities of activated Factor IX Chapel Hill and IXa alpha were similar, but both activities were less than 20% of the clotting activity of Factor IXa beta. Activated Factor IX activity was also measured in the absence of calcium, phospholipid, and Factor VIII, by determination of the rate of Factor X activation in the presence of polylysine. In the presence of polylysine, the rates of Factor X activation by activated Factor IX Chapel Hill, Factor IXa alpha, and Factor IXa beta were essentially identical. We conclude that the clotting activity of activated Factor IX Chapel Hill is reduced when compared with that of Factor IXa beta but essentially normal when compared with that of Factor IXa alpha.
D001777:Blood Coagulation; D002118:Calcium / Q000494:pharmacology; D004798:Enzymes / Q000502:physiology*; D005164:Factor IX / Q000502:physiology*; D015949:Factor IXa; D005170:Factor X / Q000378:metabolism; D006801:Humans; D011107:Polylysine / Q000494:pharmacology; D012685:Sepharose / Q000494:pharmacology; D014757:Viper Venoms / Q000494:pharmacology
D004798:Enzymes; D014757:Viper Venoms; D011107:Polylysine; C038697:factor IX Chapel Hill; D005164:Factor IX; D005170:Factor X; D012685:Sepharose; D015949:Factor IXa; D002118:Calcium